The Oncology Institute, Inc.
TOI
$3.76
$0.092.45%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 30.29M | 39.74M | 49.67M | 47.40M | 46.36M |
Total Receivables | 55.94M | 49.67M | 48.68M | 54.86M | 54.37M |
Inventory | 15.79M | 12.31M | 10.04M | 10.11M | 11.32M |
Prepaid Expenses | 2.78M | 5.11M | 4.03M | 4.06M | 4.16M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 104.79M | 106.82M | 112.42M | 116.43M | 116.21M |
|
|||||
Total Current Assets | 104.79M | 106.82M | 112.42M | 116.43M | 116.21M |
Net Property, Plant & Equipment | 34.74M | 35.33M | 37.67M | 39.36M | 39.22M |
Long-term Investments | 7.23M | 7.23M | 7.23M | 7.23M | 7.23M |
Goodwill | 7.23M | 7.23M | 7.23M | 7.23M | 7.23M |
Total Other Intangibles | 12.45M | 14.04M | 14.81M | 15.58M | 16.36M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 586.00K | 591.00K | 589.00K | 588.00K | 582.00K |
Total Assets | 159.80M | 164.00M | 172.72M | 179.18M | 179.60M |
|
|||||
Total Accounts Payable | 34.93M | 29.29M | 24.32M | 24.57M | 15.75M |
Total Accrued Expenses | 8.98M | 8.38M | 12.98M | 8.44M | 6.28M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 6.99M | 6.85M | 6.84M | 6.79M | 6.56M |
Total Finance Division Other Current Liabilities | 13.88M | 15.02M | 8.08M | 6.96M | 6.51M |
Total Other Current Liabilities | 13.88M | 15.02M | 8.08M | 6.96M | 6.51M |
Total Current Liabilities | 64.78M | 59.54M | 52.22M | 46.76M | 35.10M |
|
|||||
Total Current Liabilities | 64.78M | 59.54M | 52.22M | 46.76M | 35.10M |
Long-Term Debt | 75.02M | 73.89M | 93.13M | 91.54M | 89.95M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 21.23M | 21.65M | 23.29M | 24.74M | 24.62M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 7.76M | 3.85M | 495.00K | 671.00K | 728.00K |
Total Liabilities | 168.78M | 158.93M | 169.13M | 163.70M | 150.40M |
|
|||||
Common Stock & APIC | 239.44M | 236.49M | 215.42M | 214.13M | 211.74M |
Retained Earnings | -247.41M | -230.40M | -210.81M | -197.63M | -181.52M |
Treasury Stock & Other | -1.02M | -1.02M | -1.02M | -1.02M | -1.02M |
Total Common Equity | -8.99M | 5.07M | 3.59M | 15.48M | 29.21M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -8.99M | 5.07M | 3.59M | 15.48M | 29.21M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -8.99M | 5.07M | 3.59M | 15.48M | 29.21M |
|